Biokinetics of uranium in the human body

Depleted Uranium: Properties, Uses, and Health Consequences

Volumn , Issue , 2006, Pages 163-182

  Leggett, R W ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 75449106601     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Bassett, S.H., Frenkel, A., Cedars, N., Van Alstine, H., Waterhouse, C., Cusson, K. (1948). The Excretion of Hexavalent Uranium Following Intravenous Administration. II. Studies on Human Subjects. Rochester, New York: University of Rochester, pp. 1-57.
2. Bernard, S.R., Struxness, E.G. (1957). A study of the distribution and excretion of uranium in man. Oak Ridge National Laboratory, Oak Ridge, TN, ORNL-2304.
3. Campbell, E.E., McInroy, J.F., Schulte, H.F. (1975). Uranium in the tissue of occupationally exposed workers. In Conference on Occupational Health: Experience with Uranium. Arlington, VA, April 28-30, 1975, ERDA 93, 1975: 324-349.
4. Donoghue, J.K., Dyson, E.D., Hislop, J.S., Leach, A.M., Spoor, N.L. (1972). Human exposure to natural uranium: a case history and analytical results from some postmortem tissues. Br J Ind Med 29: 81-89.
5. Etherington, G. (2004). The solubility of inhaled DU and its influence on urine excretion. Depleted uranium oversight board, Great Britain. Available online at http://www.duob.org.uk/solubility.pdf.
6. Fisenne, I.M., Welford, G.A. (1986). Natural U concentrations in soft tissues and bone of New York City residents. Health Phys 50: 739-746.
7. Harrison, J.D., Metivier, H., Leggett, R.W., Nosske, D., Paquet, F., Phipps, A., Taylor, D. (2001). Reliability of the ICRP’s dose coefficients for members of the public. II. Uncertainties in the absorption of ingested radionuclides and the effect on dose estimates. Radiat Prot Dosimetry 95: 295-308.
8. Hursh, J.B., Spoor, N.L. (1973). Data on man. In Hodge, H.C., Stannard, J.N., Hursh, J.B., Eds., Uranium, Plutonium, Transplutonic Elements: Handbook of Experimental Pharmacology, Vol. 36. New York: Springer-Verlag, pp. 197-240.
9. ICRP (1975). Report of the task group on reference man. ICRP (International Commission on Radiological Protection) Publication 23. Oxford: Pergamon Press.
10. ICRP (1991). 1990 recommendations of the International Commission on Radiological Protection. ICRP (International Commission on Radiological Protection) Publication 60. Oxford: Pergamon Press.
11. ICRP (1994a). Human respiratory tract model for radiological protection. ICRP (International Commission on Radiological Protection) Publication 66. Oxford: Pergamon Press.
12. ICRP (1994b). Dose coefficients for intakes of radionuclides by workers. ICRP (International Commission on Radiological Protection) Publication 68. Oxford: Pergamon Press.
13. ICRP (1995a). Age-dependent doses to members of the public from intake of radionuclides: Part 3. ICRP (International Commission on Radiological Protection) Publication 69. Oxford: Pergamon Press.
14. ICRP (1995b). Age-dependent doses to members of the public from intake of radionuclides: Part 4. ICRP (International Commission on Radiological Protection) Publication 71. Oxford: Pergamon Press.
15. ICRP (2002a). Supporting guidance 3. Guide for the practical application of the ICRP human respiratory tract model. International Commission on Radiological Protection. Oxford: Pergamon Press.
16. ICRP (2002b). Basic anatomic and physiological data for use in radiological protection: reference values. ICRP (International Commission on Radiological Protection) Publication 89. Oxford: Pergamon Press;
17. Igarashi, Y., Yamakawa, A., Seki, R., Ikeda, N. (1985). Determination of U in Japanese human tissues by the fission track method. Health Phys 49: 707-712.
18. Kathren, R.L., McInroy, J.F., Moore, R.H., Dietert, S.E. (1989). Uranium in the tissues of an occupationally exposed individual. Health Phys 57: 17-21.
19. Leggett, R.W. (1989). The behavior and chemical toxicity of uranium in the kidney: a reassessment. Health Phys 57: 365-383.
20. Leggett, R.W. (1992). A generic age-specific biokinetic model for calcium-like elements, Radiat Prot Dosimetry 41: 183-198.
21. Leggett, R.W. (1994). Basis for the ICRP’s age-specific biokinetic model for uranium. Health Phys 67: 589-610.
22. Leggett, R.W., Eckerman, K.F., Boice, J.D. (2005). A respiratory model for uranium aluminide based on occupational data. J Radiol Prot 25: 1-12.
23. Leggett, R.W., Harrison, J.D. (1995). Fractional absorption of ingested U in humans. Health Phys 68: 484-498.
24. Leggett, R.W., Pellmar, T.C. (2003). The biokinetics of uranium migrating from embedded DU fragments. J Environ Radioact 64: 205-225.
25. Luessenhop, A.J., Gallimore, J.C., Sweet, W.H., Struxness, E.G., Robinson, J. (1958). The toxicity in man of hexavalent uranium following intravenous administration. Am J Roentgenol 79: 83-100.
26. Pellmar, T.C., Fuciarelli, A.F., Ejnik J.W., Hamilton, M., Hogan, J., Strocko, S., Emond, C., Mottaz, H.M., Landauer, M.R. (1999). Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol Sci 49, 29-39.
27. Rich, B.L., Hinnefeld, S.L., Lagerquist, C.L., Mansfield, W.G., Munson, L.H., Wagner, E.R. (1988). Manual of Good Practices at Uranium Facilities - Draft. EGG-2530. Idaho Falls, Idaho: Idaho National Engineering Laboratory.
28. Roberts, A.M., Coulston, D.J., Bates, T.H. (1977). Confirmation of in vivo uranium-in-chest survey by analysis of autopsy specimens. Health Phys. 32: 435-437.
29. Singh, N.P., Bennett, D.B., Wrenn, M.E., Saccomanno, G. (1987). Concentrations of alphaemitting isotopes of U and Th in uranium miners’ and millers’ tissues. Health Phys 53: 261-265.
30. Singh, N.P., Lewis, L.L., Wrenn, M.E. (1986). Uranium in human tissues of Colorado, Pennsylvania and Utah populations. In Thirty-first annual meeting of the Health Physics Society, Vol. 50, June 29-July 3. Pittsburgh, Pennsylvania. New York: Pergamon Press, S83 (abstract).
31. Spoor, N.L., Hursh, J.B. (1973). Protection criteria. In Hodge, H.C., Stannard, J.N., Hursh, J.B., Eds., Uranium, Plutonium, Transplutonic Elements: Handbook of Experimental Pharmacology, Vol. 36. New York: Springer-Verlag, pp. 241-270, chap. 5.
32. Squibb, K.S., Leggett, R.W., McDiarmid, M. (2005). Prediction of renal concentrations of depleted uranium and radiation dose in Gulf War veterans with embedded shrapnel. Health Phys 89: 267-273.
33. Struxness, E.G., Luessenhop, A.J., Bernard, S.R., Gallimore, J.C. (1956). The distribution and excretion of hexavalent uranium in man. In Proceedings of international conference on the peaceful uses of atomic energy, 1955. New York: United Nations, pp. 186-195.
34. Terepka, A.R., Toribara, T.Y., Neuman, W.F. (1966). Skeletal retention of uranium in man. Abstract 22, 46th meeting of the endocrine society, San Francisco, CA, 1964. Nucl Sci Abstr 20(3664), p. 439.
35. U.S. Department of Defense (2001). Environmental Exposure Report. Depleted Uranium in the Gulf (II) Bernard Rostker, Special Assistant for Gulf War Illnesses. Available online at http://www.deploymentlink.osd.mil/du_library/du_ii/du_ii_tabo1.htm.
36. Voegtlin, C. and Hodge, H. C., Eds. (1953). Pharmacology and Toxicology of Uranium Compounds. National Nuclear Energy Series, Division VI - Vol. I, Parts III and IV. New York: McGraw-Hill.
37. Wrenn, M.E., Durbin, P.W., Howard, B., Lipsztein, J., Rundo, J., Still, E.T., Willis, D.L. (1985). Metabolism of ingested U and Ra. Health Phys 48: 601-633.